OUR
APPROACH

CORPORATE STRATEGY

Our strategy is to leverage our Drug Discovery Platform to develop new Drug Candidates for the treatment of cancer and other serious medical conditions.

Drug Discovery

Conduct all screening and pre-clinical research at our in-house state of the art laboratory facilities

Intellectual Property

Expand and protect the technology, inventions, and trade secrets that are critical for our business

AI Based Bioinformatics

Leverage proprietary bioinformatics platform to develop novel cannabinoid formulations & research programs

Regulatory Affairs

Follow FDA targeted Regulatory Affairs strategy & clinical development programs

THE CANNABICS APPROACH

Cannabics’s revolutionary lab uses a bioinformatics platform for rapid evaluation of the therapeutic effects of thousands of compounds against a growing library of cancer cell lines and biopsies. Features of the platform include: